secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytomX Therapeutics, Inc. (CTMX)
CIK:        0001501989
Form:       8-K
Filed at:   2022-09-13T23:59:59+00:00
Accession:  0001193125-22-243709
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CytomX enters consulting agreements with former COO and CFO
-----------------------------------------------------------

- Amy Peterson, former President and COO, to provide consulting at $500/hour effective Sept 13, 2022.
- Carlos Campoy, SVP and CFO, to provide consulting at $500/hour effective Oct 1, 2022.
- Both agreements have one-year terms with 30-day termination notice.
- Peterson's services include clinical development; Campoy provides biotech and financial advice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501989/000119312522243709/0001193125-22-243709-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501989/000119312522243709/d335361d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-243709

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer